These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8527286)

  • 1. A comparison of the contractile effects of 5-hydroxytryptamine, sumatriptan and MK-462 on human coronary artery in vitro.
    Ferro A; Longmore J; Hill RG; Brown MJ
    Br J Clin Pharmacol; 1995 Sep; 40(3):245-51. PubMed ID: 8527286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-HT1D receptor agonists and human coronary artery reactivity in vitro: crossover comparisons of 5-HT and sumatriptan with rizatriptan and L-741,519.
    Longmore J; Boulanger CM; Desta B; Hill RG; Schofield WN; Taylor AA
    Br J Clin Pharmacol; 1996 Oct; 42(4):431-41. PubMed ID: 8904614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptor agonist L-775,606 with the mixed 5-HT1B/1D-receptor agonist sumatriptan and 5-HT in human isolated coronary artery.
    Longmore J; Maguire JJ; MacLeod A; Street L; Schofield WN; Hill RG
    Br J Clin Pharmacol; 2000 Feb; 49(2):126-31. PubMed ID: 10671906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
    Ellwood AJ; Curtis MJ
    Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619.
    Cocks TM; Kemp BK; Pruneau D; Angus JA
    Br J Pharmacol; 1993 Sep; 110(1):360-8. PubMed ID: 8220898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques.
    Nilsson T; Longmore J; Shaw D; Pantev E; Bard JA; Branchek T; Edvinsson L
    Eur J Pharmacol; 1999 May; 372(1):49-56. PubMed ID: 10374714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.
    Kemp BK; Cocks TM
    Br J Pharmacol; 1995 Oct; 116(4):2183-90. PubMed ID: 8564247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the vasoconstrictor properties of the 5-HT1D-receptor agonists rizatriptan (MK-462) and sumatriptan in human isolated coronary artery: outcome of two independent studies using different experimental protocols.
    Longmore J; Hargreaves RJ; Boulanger CM; Brown MJ; Desta B; Ferro A; Schofield WN; Taylor AA; Hill RG
    Funct Neurol; 1997; 12(1):3-9. PubMed ID: 9127118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of contractile responses to donitriptan and sumatriptan in the human middle meningeal and coronary arteries.
    van den Broek RW; MaassenVanDenBrink A; Mulder PG; Bogers AJ; Avezaat CJ; John GW; Saxena PR
    Eur J Pharmacol; 2002 May; 443(1-3):125-32. PubMed ID: 12044802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin-induced contraction in canine coronary artery and saphenous vein: role of a 5-HT1D-like receptor.
    Cushing DJ; Baez M; Kursar JD; Schenck K; Cohen ML
    Life Sci; 1994; 54(22):1671-80. PubMed ID: 7909909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GR127935 is a potent antagonist of the 5-HT1-like receptor mediating contraction in the canine coronary artery.
    TerrĂ³n JA
    Eur J Pharmacol; 1996 Apr; 300(1-2):109-12. PubMed ID: 8741174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No contractile effect for 5-HT1D and 5-HT1F receptor agonists in human and bovine cerebral arteries: similarity with human coronary artery.
    Bouchelet I; Case B; Olivier A; Hamel E
    Br J Pharmacol; 2000 Feb; 129(3):501-8. PubMed ID: 10711348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries. 5-HT1-like receptors resemble cloned 5-HT1D beta receptors.
    Kaumann AJ; Frenken M; Posival H; Brown AM
    Circulation; 1994 Sep; 90(3):1141-53. PubMed ID: 8087924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participation of 5-HT1-like and 5-HT2A receptors in the contraction of human temporal artery by 5-hydroxytryptamine and related drugs.
    Verheggen R; Freudenthaler S; Meyer-Dulheuer F; Kaumann AJ
    Br J Pharmacol; 1996 Jan; 117(2):283-92. PubMed ID: 8789380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the endothelium and nitric oxide on the contractile responses evoked by 5-HT1D receptor agonists in the rabbit isolated saphenous vein.
    Valentin JP; Bonnafous R; John GW
    Br J Pharmacol; 1996 Sep; 119(1):35-42. PubMed ID: 8872354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contractile responses evoked by dihydroergotamine, naratriptan and sumatriptan in the canine isolated coronary artery.
    Valentin JP; Bonnafous R; John GW
    Fundam Clin Pharmacol; 1998; 12(2):152-7. PubMed ID: 9565768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT1B-receptors and vascular reactivity in human isolated blood vessels: assessment of the potential craniovascular selectivity of sumatriptan.
    Razzaque Z; Pickard JD; Ma QP; Shaw D; Morrison K; Wang T; Longmore J
    Br J Clin Pharmacol; 2002 Mar; 53(3):266-74. PubMed ID: 11874390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sumatriptan contracts large coronary arteries of beagle dogs through 5-HT1-like receptors.
    Parsons AA; Stutchbury C; Raval P; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Nov; 346(5):592-6. PubMed ID: 1335128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the vasoconstrictor effects of rizatriptan and sumatriptan in human isolated cranial arteries: immunohistological demonstration of the involvement of 5-HT1B-receptors.
    Longmore J; Razzaque Z; Shaw D; Davenport AP; Maguire J; Pickard JD; Schofield WN; Hill RG
    Br J Clin Pharmacol; 1998 Dec; 46(6):577-82. PubMed ID: 9862247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats.
    MacLean MR; Sweeney G; Baird M; McCulloch KM; Houslay M; Morecroft I
    Br J Pharmacol; 1996 Nov; 119(5):917-30. PubMed ID: 8922741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.